ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6004
-0.01%
Brent Oil
83.855
0.31%
Bitcoin
66,606.85
0.50%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) Noticias

CMRX

Chimerix (CMRX)

Chimerix Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CMRX
FechaHoraFuenteTítuloSímboloCompañía
05/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMRXChimerix Inc
01/05/202406:00GlobeNewswire Inc.Chimerix Reports First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
24/04/202406:00GlobeNewswire Inc.Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024NASDAQ:CMRXChimerix Inc
16/04/202415:05GlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
21/03/202406:00GlobeNewswire Inc.Chimerix Appoints Marc D. Kozin to Board of DirectorsNASDAQ:CMRXChimerix Inc
29/02/202408:20Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CMRXChimerix Inc
29/02/202407:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CMRXChimerix Inc
29/02/202406:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
29/02/202406:00GlobeNewswire Inc.Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
27/02/202406:00GlobeNewswire Inc.Chimerix to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:CMRXChimerix Inc
22/02/202406:00GlobeNewswire Inc.Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024NASDAQ:CMRXChimerix Inc
16/02/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
14/02/202416:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CMRXChimerix Inc
14/02/202412:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CMRXChimerix Inc
02/01/202410:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
29/12/202306:00GlobeNewswire Inc.Chimerix Appoints Lisa Decker to Board of DirectorsNASDAQ:CMRXChimerix Inc
04/12/202306:00GlobeNewswire Inc.Chimerix Promotes Michelle LaSpaluto to Chief Financial OfficerNASDAQ:CMRXChimerix Inc
24/11/202306:00GlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
16/11/202306:00GlobeNewswire Inc.Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial OfficerNASDAQ:CMRXChimerix Inc
02/11/202307:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
02/11/202306:00GlobeNewswire Inc.Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
26/10/202306:00GlobeNewswire Inc.Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023NASDAQ:CMRXChimerix Inc
29/09/202315:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CMRXChimerix Inc
05/09/202306:00GlobeNewswire Inc.Chimerix to Participate in Upcoming Investor ConferencesNASDAQ:CMRXChimerix Inc
16/08/202309:05GlobeNewswire Inc.Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"NASDAQ:CMRXChimerix Inc
03/08/202306:00GlobeNewswire Inc.Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
27/07/202306:00GlobeNewswire Inc.Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023NASDAQ:CMRXChimerix Inc
27/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMRXChimerix Inc
27/06/202315:05GlobeNewswire Inc.Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive OfficerNASDAQ:CMRXChimerix Inc
12/06/202315:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMRXChimerix Inc
 Showing the most relevant articles for your search:NASDAQ:CMRX

Su Consulta Reciente

EU
FLUX
Fluxys Belgium
NEO
CQLU
CIBC QX US Low Volatilit...
LSE
77TV
Sg Issuer 23
COIN
USDRUST
Remitt USD
XE
PR1T
Amundi Luxembourg
AMEX
SPTI
SPDR Portfolio Intermedi...
LSE
81FJ
Qnb Fin 26
TG
JAL
Japan AIrlines
LSE
SJ66
Qnb Fin 32
LSE
15QF
Sg Issuer 26
COIN
TOHGBP
USOTC
JGGIF
JP Morgan Fleming Overse... (PK)
BIT
1SEBA
Skandinaviska Enskilda B...
TG
ISQP
BlackRock Institutional ...
EU
REINA
Reinet Investments SCA
TG
MWOP
Amundi Index Solutions
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados